BRPI0907951A2 - Uso combinado de 25-hidroxivitamina d3 e vitamina d3 para melhorar a densidade mineral do osso e para tratar a osteoporose - Google Patents

Uso combinado de 25-hidroxivitamina d3 e vitamina d3 para melhorar a densidade mineral do osso e para tratar a osteoporose

Info

Publication number
BRPI0907951A2
BRPI0907951A2 BRPI0907951-3A BRPI0907951A BRPI0907951A2 BR PI0907951 A2 BRPI0907951 A2 BR PI0907951A2 BR PI0907951 A BRPI0907951 A BR PI0907951A BR PI0907951 A2 BRPI0907951 A2 BR PI0907951A2
Authority
BR
Brazil
Prior art keywords
hydroxyvitamin
vitamin
combined use
bone mineral
mineral density
Prior art date
Application number
BRPI0907951-3A
Other languages
English (en)
Inventor
Neil Robert Buck
Wouter Claerhout
Bruno H Leuenberger
Elisabeth Stoecklin
Kai Urban
Swen Wolfram
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0907951A2 publication Critical patent/BRPI0907951A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0907951-3A 2008-02-13 2009-02-12 Uso combinado de 25-hidroxivitamina d3 e vitamina d3 para melhorar a densidade mineral do osso e para tratar a osteoporose BRPI0907951A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2851008P 2008-02-13 2008-02-13
US3167108P 2008-02-26 2008-02-26
US3692208P 2008-03-14 2008-03-14
US3692808P 2008-03-15 2008-03-15
PCT/EP2009/051639 WO2009101135A1 (en) 2008-02-13 2009-02-12 Combined use of 25-hydroxy-vitamin d3 and vitamin d3 for improving bone mineral density and for treating osteoporosis

Publications (1)

Publication Number Publication Date
BRPI0907951A2 true BRPI0907951A2 (pt) 2015-08-04

Family

ID=40551383

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907951-3A BRPI0907951A2 (pt) 2008-02-13 2009-02-12 Uso combinado de 25-hidroxivitamina d3 e vitamina d3 para melhorar a densidade mineral do osso e para tratar a osteoporose

Country Status (12)

Country Link
US (1) US20110039809A1 (pt)
EP (1) EP2240181A1 (pt)
JP (1) JP5509504B2 (pt)
KR (2) KR20100126376A (pt)
CN (2) CN101951919A (pt)
AU (1) AU2009214052B2 (pt)
BR (1) BRPI0907951A2 (pt)
EA (1) EA018580B1 (pt)
HK (1) HK1212210A1 (pt)
IL (1) IL207592A0 (pt)
MX (1) MX2010008906A (pt)
WO (1) WO2009101135A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
KR20190028822A (ko) 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US20110052707A1 (en) * 2008-02-12 2011-03-03 Neil Robert Buck Combination of vitamin d and 25-hydroxyvitamin d 3
IT1393945B1 (it) * 2009-04-21 2012-05-17 Fidia Farmaceutici Composizioni comprendenti acido ialuronico, acido ialuronico solfatato, calcio e vitamina d3 nel trattamento delle malattie osteoarticolari e muscoloscheletriche
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
RU2497533C1 (ru) * 2012-04-19 2013-11-10 Общество С Ограниченной Ответственностью "Парафарм" Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
JP2017523220A (ja) * 2014-08-07 2017-08-17 オプコ アイルランド グローバル ホールディングス リミテッド ２５−ヒドロキシビタミンｄを用いる補助的療法
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN107105712A (zh) * 2015-01-15 2017-08-29 帝斯曼知识产权资产管理有限公司 预防家禽肥胖和心血管问题的方法
DK3090638T3 (da) * 2015-04-20 2020-08-10 Bernd-Michael Löffler Kosttilskud til behandling af vitamin-d3-mangelsymptomer
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法
EP3515212B1 (en) * 2016-09-23 2024-07-24 Quincy Bioscience LLC Apoaequorin and vitamin d-containing compositions and methods of using same
CN110338425A (zh) * 2018-04-08 2019-10-18 北京奥萨医药研究中心有限公司 一种防护骨质疏松的营养补充剂
CN108902985A (zh) * 2018-06-08 2018-11-30 唐飞 25-羟基维生素d3在制备保健食品中的应用
CN108720025A (zh) * 2018-06-08 2018-11-02 唐飞 25-羟基维生素d3在食品中的应用
IT201900007202A1 (it) * 2019-05-24 2020-11-24 Pavia Farm S R L Composizione a base di vitamine liposolubili ad elevato assorbimento enterico
WO2022224001A1 (en) * 2021-04-22 2022-10-27 Faes Farma, S.A. Universal dosage regime of 25-hydroxy vitamin d3
CN114088855B (zh) * 2021-11-16 2022-10-28 河南农业大学 一种肉鸡胫骨软骨发育不良早期诊断粪便生物标志物及其应用
CN117503708A (zh) * 2023-09-27 2024-02-06 济南维瑞医药科技开发有限公司 一种佝偻病患儿专用补钙剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US7050832B2 (en) * 2001-11-28 2006-05-23 Arraycomm Llc Variable diversity transmission in a radio communications system based on characteristics of a received signal
US7632518B2 (en) * 2002-01-15 2009-12-15 Dsm Ip Assets B.V. 25-hydroxy vitamin D3 compositions
EP1516540B1 (en) * 2003-09-22 2012-09-26 DSM IP Assets B.V. Use of vitamin D compounds
EP1662896B1 (en) * 2003-09-22 2012-10-24 DSM IP Assets B.V. Vitamin containing pet food compositions
EP1917071B1 (en) * 2005-08-18 2014-01-08 DSM IP Assets B.V. Use of 25-hydroxy vitamin d3 to improve male animal fertility
CA2624897C (en) * 2005-10-12 2017-02-14 Proventiv Therapeutics, Llc Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
WO2007059960A1 (en) * 2005-11-25 2007-05-31 Dsm Ip Assets B.V. Use of 25-hydroxy vitamin d3 to improve vitality of animals
ES2593047T3 (es) * 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3

Also Published As

Publication number Publication date
IL207592A0 (en) 2010-12-30
JP2011512343A (ja) 2011-04-21
JP5509504B2 (ja) 2014-06-04
EA018580B1 (ru) 2013-09-30
EP2240181A1 (en) 2010-10-20
EA201001286A1 (ru) 2010-12-30
AU2009214052B2 (en) 2015-05-07
CN101951919A (zh) 2011-01-19
WO2009101135A1 (en) 2009-08-20
KR20150103336A (ko) 2015-09-09
MX2010008906A (es) 2010-11-05
US20110039809A1 (en) 2011-02-17
AU2009214052A1 (en) 2009-08-20
CN104758301A (zh) 2015-07-08
HK1212210A1 (en) 2016-06-10
KR20100126376A (ko) 2010-12-01

Similar Documents

Publication Publication Date Title
BRPI0907951A2 (pt) Uso combinado de 25-hidroxivitamina d3 e vitamina d3 para melhorar a densidade mineral do osso e para tratar a osteoporose
BRPI0907953A2 (pt) Uso de 25-hidroxivitamina d3 para afetar a fisiologia do músculo humano
BRPI0921433A2 (pt) uso de anticorpos anti-cs1 para o tratamento de linfomas raros
BRPI0908428A2 (pt) uso de ranozalina para tratar a dor.
BR112012010258A2 (pt) Método e dispositivo para desossar um osso na perna
BRPI0810620A2 (pt) uso de elastômeros para produzir géis para tratar um furo de poço
BR212013028314U2 (pt) método para tratar câncer e dor de câncer de osso
AR092794A1 (es) Compuestos para tratar la atrofia muscular espinal
BRPI0817748A2 (pt) Dispositivo para tratar um osso.
BR112014004089A2 (pt) implantes e métodos para usar os implantes para encher furos em tecido ósseo
BRPI0914752A2 (pt) fórceps ósseo para segurar placas e método de uso
BRPI0911290A2 (pt) âncora universal para ligar objetos ao tecido ósseo
BR112012005076A2 (pt) componentes para rosqueamento de osso
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BR112012029480A2 (pt) propantes para uso em fratura hidráulica de formações subterrâneas
BRPI0905983A2 (pt) Método e aparelho para calcinação de gesso pressurizado
BR112014013847A2 (pt) uso de dispositivos para tratar patologias da coluna vertebral
BRPI1014858A2 (pt) "antagonistas de bmp-alk3 e usos para promover o crescimento ósseo"
CL2007002837A1 (es) Uso de fenitoina para tratar mucositis oral.
BR112012005077A2 (pt) componentes para rosqueamento de osso
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
BRPI1006024B8 (pt) composição cosmética emulsificada para cuidado da pele
BR112012028719A2 (pt) composição de tratamento de superfície dura, método para fornecer um efeito antimicrobiano a uma superfície dura e uso de uma combinação
CO6862163A2 (es) Carbonato de calcio con tratamiento de superficie para la unión y biorremediación de composiciones que contienen hidrocarburos
IL207589A0 (en) Combination of vitamin d and 25-hydroxyvitamin d3

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/593 (2006.01), A23L 33/155 (2016.01), A61P

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL